Chris Hlynialuk

473 total citations
9 papers, 332 citations indexed

About

Chris Hlynialuk is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Chris Hlynialuk has authored 9 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 4 papers in Molecular Biology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Chris Hlynialuk's work include Alzheimer's disease research and treatments (6 papers), Neuroscience and Neuropharmacology Research (4 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Chris Hlynialuk is often cited by papers focused on Alzheimer's disease research and treatments (6 papers), Neuroscience and Neuropharmacology Research (4 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Chris Hlynialuk collaborates with scholars based in United States, Germany and Canada. Chris Hlynialuk's co-authors include Karen H. Ashe, Benjamin R. Smith, Martin Ramsden, James Cleary, Xiaohui Zhao, Kathleen R. Zahs, Linda Kotilinek, Lisa J. Kemper, Kellie Benzow and Michael D. Koob and has published in prestigious journals such as Nature Medicine, Nature Communications and Journal of Neuroscience.

In The Last Decade

Chris Hlynialuk

9 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris Hlynialuk United States 6 210 140 121 89 51 9 332
Levi M. Smith United States 8 253 1.2× 169 1.2× 161 1.3× 90 1.0× 75 1.5× 9 405
Lisa J. Kemper United States 7 188 0.9× 104 0.7× 99 0.8× 79 0.9× 38 0.7× 10 272
Isabel Hilbrich Germany 9 219 1.0× 155 1.1× 85 0.7× 57 0.6× 54 1.1× 10 332
Vanessa Plouffe Canada 5 282 1.3× 152 1.1× 133 1.1× 88 1.0× 38 0.7× 5 346
An Schreurs Belgium 5 162 0.8× 94 0.7× 116 1.0× 61 0.7× 39 0.8× 7 293
Maria Merezhko Finland 5 263 1.3× 167 1.2× 91 0.8× 112 1.3× 43 0.8× 5 380
Cristina Vergara Spain 10 219 1.0× 205 1.5× 71 0.6× 113 1.3× 30 0.6× 19 368
Bianca T. Corjuc United States 3 396 1.9× 152 1.1× 128 1.1× 130 1.5× 79 1.5× 3 462
Guenther Daum Austria 5 182 0.9× 245 1.8× 79 0.7× 55 0.6× 35 0.7× 6 419
Diana S. Himmelstein United States 6 266 1.3× 169 1.2× 89 0.7× 59 0.7× 90 1.8× 6 374

Countries citing papers authored by Chris Hlynialuk

Since Specialization
Citations

This map shows the geographic impact of Chris Hlynialuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Hlynialuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Hlynialuk more than expected).

Fields of papers citing papers by Chris Hlynialuk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Hlynialuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Hlynialuk. The network helps show where Chris Hlynialuk may publish in the future.

Co-authorship network of co-authors of Chris Hlynialuk

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Hlynialuk. A scholar is included among the top collaborators of Chris Hlynialuk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Hlynialuk. Chris Hlynialuk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Liu, Peng, et al.. (2024). Aβ∗56 is a stable oligomer that impairs memory function in mice. iScience. 27(3). 109239–109239. 3 indexed citations
3.
Hlynialuk, Chris, et al.. (2022). Caspase-2 mRNA levels are not elevated in mild cognitive impairment, Alzheimer’s disease, Huntington’s disease, or Lewy Body dementia. PLoS ONE. 17(9). e0274784–e0274784. 3 indexed citations
4.
Singh, Gurpreet, Peng Liu, Jessica M. Strasser, et al.. (2022). Caspase-2 Inhibitor Blocks Tau Truncation and Restores Excitatory Neurotransmission in Neurons Modeling FTDP-17 Tauopathy. ACS Chemical Neuroscience. 13(10). 1549–1557. 7 indexed citations
5.
Benzow, Kellie, Colleen L. Forster, Lisa J. Kemper, et al.. (2019). Factors other than hTau overexpression that contribute to tauopathy-like phenotype in rTg4510 mice. Nature Communications. 10(1). 2479–2479. 118 indexed citations
6.
Kemper, Lisa J., Chris Hlynialuk, Kellie Benzow, et al.. (2019). Developmental Pathogenicity of 4-Repeat Human Tau Is Lost with the P301L Mutation in Genetically Matched Tau-Transgenic Mice. Journal of Neuroscience. 40(1). 220–236. 14 indexed citations
7.
Zhao, Xiaohui, Linda Kotilinek, Benjamin R. Smith, et al.. (2016). Caspase-2 cleavage of tau reversibly impairs memory. Nature Medicine. 22(11). 1268–1276. 144 indexed citations
9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026